10.2 Sterile Compounding: USP <797> & the Massachusetts Overlay
Key Takeaways
- Sterile compounding in Massachusetts requires a licence under M.G.L. c. 112, §§ 39G, 39I and 39J and 247 CMR 6.06/6.08, and is measured against USP <797>; the Board's 247 CMR 17.00 remains a draft rather than a promulgated regulation.
- Under 247 CMR 6.01(5)(c) sterile compounding may not be conducted at a pharmacy without a Board-approved clean room.
- A pharmacist who oversees or is directly engaged in sterile compounding must complete at least 5 contact hours of sterile compounding continuing education each calendar year.
- 247 CMR 20.06 requires a sterile compounding pharmacy to report any defective compounded sterile preparation within seven days of identification, and to report above-action-level environmental monitoring results and failure of certification of a primary or secondary engineering control.
- USP <797> assigns beyond-use dates by compounding category and requires personnel competency, gowning, garbing, aseptic technique and environmental monitoring appropriate to the engineering controls in use.
Compounded Sterile Preparations (CSPs) include intravenous infusions, total parenteral nutrition (TPN) bags, epidural injections, ophthalmic solutions, intrathecal medications, and inhalation solutions. Because CSPs bypass the body's natural protective barriers (skin and gastrointestinal tract), contamination with microorganisms, bacterial endotoxins (pyrogens), or airborne particulate matter can result in severe systemic infection or death. Sterile compounding in the U.S. is governed by USP General Chapter <797> (Pharmaceutical Compounding — Sterile Preparations) and USP General Chapter <800> (Hazardous Drugs — Handling in Healthcare Settings). In Massachusetts, these federal standards are reinforced and strictly enforced under 247 CMR 17.00 (Sterile Compounding).
Cleanroom Architecture & ISO Engineering Controls
USP <797> relies on a system of environmental controls categorized by International Organization for Standardization (ISO) air cleanliness ratings. ISO standards limit the maximum number of airborne particles $\ge 0.5\text{ }\mu\text{m}$ per cubic meter of air. Lower ISO class numbers represent cleaner air environments:
| Engineering Control / Room | ISO Air Cleanliness Class | Max Particles ($\ge 0.5\text{ }\mu\text{m}/\text{m}^3$) | Description & Airflow Function |
|---|---|---|---|
| Primary Engineering Control (PEC) | ISO Class 5 | 3,520 | The critical area where sterile compounding occurs. Includes Laminar Airflow Workbenches (LAFW), Compounding Aseptic Isolators (CAI), Class II Biological Safety Cabinets (BSC), and Compounding Aseptic Containment Isolators (CACI). Must maintain unidirectional HEPA-filtered air across the direct compounding area (DCA). |
| Buffer Room (Cleanroom) | ISO Class 7 | 352,000 | The room housing the PEC. Must maintain positive pressure relative to adjacent areas ($\ge 0.02\text{ to }0.05\text{ inches}$ water gauge) for non-hazardous compounding, or negative pressure for hazardous compounding. |
| Anteroom | ISO Class 8 (or ISO Class 7) | 3,520,000 | The room adjacent to the buffer room used for garbing, hand hygiene, order entry, staging, and unpacking supplies. Must be ISO Class 8 if opening into a positive-pressure non-HD buffer room, but MUST be ISO Class 7 if opening into a negative-pressure HD buffer room. |
| Unclassified Space | Unclassified | $> 3,520,000$ | Standard ambient pharmacy room air. |
PEC Operational Rule: PECs must run continuously. If a PEC is powered off, it must be thoroughly cleaned and disinfected, and operated continuously for at least 30 minutes prior to initiating sterile compounding.
Garbing and Hand Hygiene Order
USP <797>, which 247 CMR 9.01(3) makes binding in Massachusetts, mandates a strict garbing sequence designed to move from dirtiest to cleanest to minimize microbial shedding in the cleanroom environment. This order is a frequent, high-yield MPJE examination topic:
- Dedicated Shoes or Shoe Covers: Don dedicated cleanroom footwear or disposable shoe covers upon crossing the cleanroom perimeter line into the anteroom.
- Head and Facial Hair Covers: Don head cover (caps) completely containing all hair, followed by facial hair covers (beard covers).
- Face Mask & Eye Shield: Don a face mask and eye protection (goggles or face visor) if non-isolator PEC is used.
- Hand Hygiene: Wash hands and forearms up to the elbows thoroughly with soap and warm water for at least 30 seconds. Dry hands with low-shedding paper towels or cleanroom hand dryer.
- Non-Shedding Gown: Don a non-shedding, low-linting gown with snug cuffs and closure at the neck.
- Antiseptic Hand Rub: Apply an alcohol-based hand rub with persistent activity to hands and forearms, allowing them to dry completely.
- Sterile Powder-Free Gloves: Don sterile, powder-free gloves inside the buffer room (or anteroom line). Cuffs of gloves must fit securely over the gown sleeves. Gloves must be sanitized repeatedly with sterile 70% Isopropyl Alcohol (IPA) during compounding.
Category 1 vs. Category 2 Compounded Sterile Preparations (CSPs)
Updated USP <797> standards eliminate the historical low/medium/high-risk scheme and categorize CSPs primarily into Category 1 and Category 2 based on the environmental conditions under which they are compounded and their assigned Beyond-Use Dates (BUDs):
Category 1 CSPs
- Compounding Environment: Compounded within an ISO Class 5 PEC located inside an unclassified Segregated Compounding Area (SCA) (a dedicated area without full cleanroom buffer/anteroom architecture).
- Maximum Beyond-Use Dates (BUDs):
- Controlled Room Temperature: 12 hours or less.
- Refrigerated (2°C to 8°C): 24 hours or less.
Category 2 CSPs
- Compounding Environment: Compounded within an ISO Class 5 PEC located inside a full ISO Class 7 Cleanroom Suite (ISO 7 buffer room with ISO 8/7 anteroom).
- Maximum Beyond-Use Dates (BUDs): Vary based on sterilization method (aseptic processing vs. terminal sterilization), sterility testing status (USP <71>), and storage temperature:
- Aseptically prepared, non-sterility tested, using sterile components: Max 4 days at Controlled Room Temp; 10 days Refrigerated; 45 days Frozen (–25°C to –10°C).
- Terminally sterilized or sterility tested: Extended BUDs up to 45 days Room Temp; 60 days Refrigerated; 90 days Frozen.
Massachusetts Board Requirements under draft 247 CMR 17.00
Massachusetts enforces rigorous oversight of sterile compounding pharmacies through licensure under 247 CMR 6.00 and the standards the Board has set out in draft 247 CMR 17.00:
- Mandatory State Licensure: No institutional, retail, or non-resident pharmacy may compound sterile preparations for distribution or dispensing in Massachusetts without holding a specialized Sterile Compounding License/Permit issued by the MA Board of Registration in Pharmacy.
- Environmental Monitoring: Pharmacies must perform certified environmental air sampling (viable fungal and bacterial pathogens, non-viable particulates) and surface sampling at least every 6 months. Any action-level environmental contamination trigger requires immediate remediation, root-cause investigation, and notification to the Board.
- Mandatory Reporting Timelines: Pharmacies must notify the Massachusetts Board in writing within 7 business days of any serious adverse event or recall involving a CSP, and within 24 hours of confirming microbial growth during environmental monitoring or batch sterility testing.
- Personnel Qualification: All compounding personnel must undergo initial and annual (or semi-annual for high-risk Category 2 operations) competency evaluations including gloved fingertip sampling (3 consecutive pass tests showing 0 CFUs) and media-fill aseptic simulation testing.
USP <800> Hazardous Drug (HD) Handling
USP General Chapter <800> applies to all healthcare personnel who handle Hazardous Drugs (HDs), which are categorized by the National Institute for Occupational Safety and Health (NIOSH) into Group 1 (Antineoplastic agents), Group 2 (Non-antineoplastic HDs), and Group 3 (Reproductive toxins only).
Engineering & Facility Controls for HDs (C-PEC, C-SEC, C-SCA)
- Containment Primary Engineering Control (C-PEC): Must be externally vented (preferred) or double-HEPA filtered in series. Examples include Class II Biological Safety Cabinets (BSCs) or Compounding Aseptic Containment Isolators (CACIs).
- Containment Secondary Engineering Control (C-SEC): HD buffer rooms MUST maintain negative pressure relative to adjacent areas ($\text{–}0.01\text{ to }\text{–}0.03\text{ inches}$ water gauge) and provide a minimum of 30 Air Changes Per Hour (ACPH) for sterile HD cleanrooms.
- Containment Segregated Compounding Area (C-SCA): An unclassified negative-pressure room with at least 12 ACPH vented externally, used exclusively for Category 1 HD compounding (BUD $\le 12$ hrs room temp / $\le 24$ hrs fridge).
- Personal Protective Equipment (PPE): HD compounding requires two pairs of chemotherapy-rated gloves (the outer glove worn over the gown cuff), an impermeable gown, eye protection, and N95/elastomeric respirators when unpacking HD active ingredients. Spill kits must be accessible in all HD storage and preparation areas.
The Massachusetts Overlay — draft 247 CMR 17.00
The Board's draft 247 CMR 17.00 would establish minimum professional standards for sterile compounding in Massachusetts. It has not been promulgated — the adopted compilation ends at 247 CMR 21.00 — so today the binding requirements are M.G.L. c. 112, §§ 39G, 39I and 39J, the sterile compounding licence in 247 CMR 6.06 and 6.08, the duty in 247 CMR 9.01(3) to follow the most current USP chapters, and Board policy. Four state-specific points sit on top of USP <797>:
- A Board-approved clean room is mandatory. Under 247 CMR 6.01(5)(c) sterile compounding may not be conducted at a pharmacy without a Board-approved clean room — a rule that reaches practices such as preparing pre-filled syringes from a sterile source.
- A separate licence is required. Sterile compounding pharmacies are licensed under M.G.L. c. 112, §§ 39G and 39I, and institutional sterile compounding is separately licensed. Original licensure follows a satisfactory Board inspection.
- Continuing education. A registrant who oversees or is directly engaged in sterile compounding, or who practises in a pharmacy licensed under § 39G or § 39I, must complete at least 5 contact hours of continuing education in sterile compounding each calendar year (247 CMR 4.03(4)(c)).
- Mandatory reporting — 247 CMR 20.06. A sterile compounding pharmacy must report within seven days of identification any defective compounded sterile preparation dispensed into or from Massachusetts, and must report above-action-level environmental monitoring results and failure of certification of a primary or secondary engineering control. It must also report annually the sterile prescriptions dispensed within and outside the Commonwealth with their volume and the states involved.
[!CAUTION] The environmental-monitoring and engineering-control reports are unusual and heavily tested. Most states treat an out-of-specification air sample or a failed hood certification as an internal quality matter. Massachusetts requires it to be reported to the Board — a direct legacy of the 2012 New England Compounding Center outbreak.
When preparing to enter the buffer room for sterile compounding, which item of Personal Protective Equipment (PPE) should be donned FIRST according to the standard garbing sequence?
Under USP <797>, a Compounded Sterile Preparation (CSP) compounded inside a Primary Engineering Control (PEC) located within an unclassified Segregated Compounding Area (SCA) is classified as what category, and what is its maximum room temperature Beyond-Use Date (BUD)?
Under USP <800> and Massachusetts regulations, what is the minimum required Air Changes Per Hour (ACPH) and pressure status for a Secondary Engineering Control (C-SEC) buffer room used for compounding sterile Hazardous Drugs (HDs)?